ArticleContemporary oncology (Poznan, Poland)2015

ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine.

Mehmet Ulker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.